Author Correction: Mutational signature-based identification of DNA repair deficient gastroesophageal adenocarcinomas for therapeutic targeting.
Saved in:
| Title: | Author Correction: Mutational signature-based identification of DNA repair deficient gastroesophageal adenocarcinomas for therapeutic targeting. |
|---|---|
| Authors: | Prosz A; Danish Cancer Institute, Copenhagen, Denmark., Sahgal P; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.; Computational Health Informatics Program, Boston Children's Hospital, Boston, MA, USA.; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard University, Cambridge, MA, USA., Huffman BM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Division of Gastrointestinal Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Sztupinszki Z; Danish Cancer Institute, Copenhagen, Denmark.; Computational Health Informatics Program, Boston Children's Hospital, Boston, MA, USA., Morris CX; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Chen D; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada., Börcsök J; Danish Cancer Institute, Copenhagen, Denmark., Diossy M; Danish Cancer Institute, Copenhagen, Denmark.; Computational Health Informatics Program, Boston Children's Hospital, Boston, MA, USA., Tisza V; Institute of Molecular Life Sciences, HUN-REN Research Centre for Natural Sciences, Budapest, Hungary., Spisak S; Institute of Molecular Life Sciences, HUN-REN Research Centre for Natural Sciences, Budapest, Hungary., Likasitwatanakul P; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard University, Cambridge, MA, USA., Rusz O; 2nd Department of Pathology, SE NAP, Brain Metastasis Research Group, Semmelweis University, Budapest, Hungary., Csabai I; Department of Physics of Complex Systems, Eötvös Loránd University, Budapest, Hungary., Cecchini M; Department of Medical Oncology, Center for Gastrointestinal Cancers, Yale Medical Center, New Haven, CT, USA., Baca Y; Caris Life Sciences, Phoenix, AZ, USA., Elliott A; Caris Life Sciences, Phoenix, AZ, USA., Enzinger P; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.; Division of Gastrointestinal Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Singh H; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.; Division of Gastrointestinal Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Ubellaker J; Department of Molecular Metabolism, Harvard T.H. Chan School of Public Health, Boston, MA, USA., Lazaro JB; Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for DNA Damage and Repair (CDDR), Dana-Farber Cancer Institute, Boston, MA, USA., Cleary JM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.; Division of Gastrointestinal Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Szallasi Z; Danish Cancer Institute, Copenhagen, Denmark. Zoltan.szallasi@childrens.harvard.edu.; Computational Health Informatics Program, Boston Children's Hospital, Boston, MA, USA. Zoltan.szallasi@childrens.harvard.edu.; Department of Bioinformatics and Department of Pathology, Forensic and Insurance Medicine, Semmelweis University, Budapest, Hungary. Zoltan.szallasi@childrens.harvard.edu., Sethi NS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. nilay_sethi@dfci.harvard.edu.; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA. nilay_sethi@dfci.harvard.edu.; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard University, Cambridge, MA, USA. nilay_sethi@dfci.harvard.edu.; Division of Gastrointestinal Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. nilay_sethi@dfci.harvard.edu. |
| Source: | NPJ precision oncology [NPJ Precis Oncol] 2024 May 06; Vol. 8 (1), pp. 98. Date of Electronic Publication: 2024 May 06. |
| Publication Type: | Published Erratum |
| Journal Info: | Publisher: Springer Nature Country of Publication: England NLM ID: 101708166 Publication Model: Electronic Cited Medium: Print ISSN: 2397-768X (Print) Linking ISSN: 2397768X NLM ISO Abbreviation: NPJ Precis Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2397-768X |
|---|---|
| DOI: | 10.1038/s41698-024-00587-w |
